Johnson Investment Counsel Inc. Has $2.45 Million Position in U.S. Physical Therapy, Inc. $USPH

Johnson Investment Counsel Inc. increased its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 35.1% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 28,794 shares of the company’s stock after buying an additional 7,477 shares during the period. Johnson Investment Counsel Inc.’s holdings in U.S. Physical Therapy were worth $2,446,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in USPH. Cullen Frost Bankers Inc. raised its stake in shares of U.S. Physical Therapy by 171.8% during the second quarter. Cullen Frost Bankers Inc. now owns 443 shares of the company’s stock valued at $35,000 after acquiring an additional 280 shares during the last quarter. Assetmark Inc. grew its stake in shares of U.S. Physical Therapy by 35.7% in the second quarter. Assetmark Inc. now owns 570 shares of the company’s stock worth $45,000 after purchasing an additional 150 shares during the last quarter. Huntington National Bank increased its holdings in U.S. Physical Therapy by 71.9% in the second quarter. Huntington National Bank now owns 667 shares of the company’s stock valued at $52,000 after purchasing an additional 279 shares during the period. Blue Trust Inc. raised its position in U.S. Physical Therapy by 35.3% during the 3rd quarter. Blue Trust Inc. now owns 640 shares of the company’s stock worth $54,000 after purchasing an additional 167 shares during the last quarter. Finally, CWM LLC lifted its holdings in U.S. Physical Therapy by 207.4% during the 2nd quarter. CWM LLC now owns 827 shares of the company’s stock worth $65,000 after buying an additional 558 shares during the period.

Wall Street Analyst Weigh In

A number of research firms have commented on USPH. Barrington Research reiterated an “outperform” rating and issued a $103.00 price target on shares of U.S. Physical Therapy in a research report on Monday, January 5th. Weiss Ratings reiterated a “hold (c)” rating on shares of U.S. Physical Therapy in a report on Wednesday, January 21st. Citigroup reissued a “market outperform” rating on shares of U.S. Physical Therapy in a research report on Monday, December 15th. Finally, JPMorgan Chase & Co. lowered their price target on shares of U.S. Physical Therapy from $110.00 to $100.00 and set an “overweight” rating for the company in a report on Monday, November 24th. Four analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $105.33.

U.S. Physical Therapy Stock Up 3.3%

Shares of NYSE:USPH opened at $88.19 on Thursday. The company has a market capitalization of $1.34 billion, a price-to-earnings ratio of 37.06, a P/E/G ratio of 3.52 and a beta of 1.30. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.20 and a quick ratio of 1.20. The business’s 50-day moving average is $82.04 and its 200-day moving average is $81.89. U.S. Physical Therapy, Inc. has a 1 year low of $62.77 and a 1 year high of $93.50.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.